Company: PRI
Filing Date: 2025-04-01
Form Type: DEF 14A
Source: 0000950170-25-048061
Chunk: 10

Company: Primerica, Inc.
Filing Date: 2025-04-01
Form: DEF 14A
Chunk 10
---
 |  65 |     | Chief Executive Officer, Primerica                                                                     |     | No          |     | April 2015             |
| Darryl L. Wilson     |     |  61 |     | Founder, Chairman and President, The Wilson Collective                                                 |     | Yes         |     | February 2024          |
| Barbara A. Yastine   |     |  66 |     | Former Chairman, President and Chief Executive Officer, Ally Bank                                      |     | Yes         |     | December 2010          |

Each director nominee attended 90% or more, collectively, of the aggregate of all meetings of our Board of Directors and its committees on which he or she served during fiscal 2024. Mr. Wilson, Ms. Cottle and Mr. Dheer were elected to our Board of Directors effective February 2024, May 2022 and October 2019, respectively. The average tenure of all of our director nominees is 9.9 years. Unless otherwise instructed, the members of the Proxy Committee (as defined in “Information About Voting and the Annual Meeting”) will vote the proxies held by them “FOR” the election to our Board of Directors of the nominees named above.

| Primerica 2025 Proxy Statement | 9 |

| MATTERS TO BE VOTED ON |

Proposal 2: Advi sory Vote on Executive Compensation (Say-on-Pay) • What am I Voting on? The Board is asking our stockholders to approve, on an advisory basis, the compensation of the named executive officers as disclosed in this Proxy Statement. • Voting Recommendation: “FOR” the proposal. • Vote Required: Approval requires a “FOR” vote by at least a majority of the shares represented at the Annual Meeting, by valid proxy or otherwise, and entitled to vote. See “Executive Compensation” beginning on page 45 for more information. We most recently sought stockholder approval of the compensation of our named executive officers at the Company's Annual Meeting of Stockholders held on May 8, 2024 (the “2024 Annual Meeting”), at which time approximately 95.1% of votes cast were in favor thereof. At the Company's Annual Meeting of Stockholders held on May 17, 2023, our stockholders supported the Board’s recommendation to hold an annual Say-on-Pay vote. The Say-on-Pay vote is not binding on the Company, our Board of Directors or the Compensation Committee. Our Board and the Compensation Committee value the